Functional Implications of Cathelicidin Antimicrobial Protein in Breast Cancer and Tumor-Associated Macrophage Microenvironment

It is well-established that tumor-associated macrophages (TAMs) play an important role in breast cancer development. Accumulating evidence suggested that human cathelicidin antimicrobial protein (<i>CAMP</i>), which is mainly expressed in host defense cells such as macrophages, is crucia...

Full description

Bibliographic Details
Main Authors: Jiawei Chen, Vivian Yvonne Shin, John Chi-Wang Ho, Man-Ting Siu, Isabella Wai-Yin Cheuk, Ava Kwong
Format: Article
Language:English
Published: MDPI AG 2020-04-01
Series:Biomolecules
Subjects:
Online Access:https://www.mdpi.com/2218-273X/10/5/688
Description
Summary:It is well-established that tumor-associated macrophages (TAMs) play an important role in breast cancer development. Accumulating evidence suggested that human cathelicidin antimicrobial protein (<i>CAMP</i>), which is mainly expressed in host defense cells such as macrophages, is crucial not only in combating microorganisms but also promoting tumor growth. Here we report the interaction of <i>CAMP</i> with TAMs in breast cancer. <i>CAMP</i> expression was upregulated in cancer tissues and in the circulation of breast cancer patients. Surgical removal of tumor decreased CAMP peptide serum level. Knockdown of <i>CAMP</i> decreased cell proliferation and migration/invasion ability in breast cancer cells. <i>CAMP</i> expression was altered during macrophage M1/M2 polarization and was expressed predominantly in M2 phenotype. In addition, breast cancer cells co-cultured with macrophages upregulated <i>CAMP</i> expression and also increased cancer cell viability. Xenograft tumors reduced significantly upon <i>CAMP</i> receptor antagonist treatment. Our data implicated that <i>CAMP</i> confers an oncogenic role in breast cancer and plays an important role in the tumor microenvironment between TAMs and breast cancer cells, and blocking the interaction between them would provide a novel therapeutic option for this malignant disease.
ISSN:2218-273X